Critical Review of Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis: Prevalence and Users’ Profile, Decision-Making, Information Seeking, and Disclosure in the Face of a Lack of Efficacy

Neurodegenerative Diseases Review Adams J.a · Lee M.b · Peng W.a Author affiliations Keywords: Amyotrophic lateral sclerosisComplementary and alternative medicineReviewPrevalenceDecision-makingInformation seekingDisclosure Neurodegener Dis 2018;18:225–232 https://doi.org/10.1159/000492946 Abstract Get article FullText PDF Login / Register Abstract Background: Despite a lack of evidence of clinical efficacy for complementary and alternative medicine (CAM) use in amyotrophic lateral sclerosis (ALS), these medicines remain popular around the world. Objective: To examine the prevalence and cost of CAM use in ALS and CAM users’ profile, decision-making, information seeking, and disclosure among ALS patients. Methods: A comprehensive literature search was conducted of MEDLINE, CINAHL/SCOPUS, and AMED databases from their inception to April 2018. This review followed PRISMA guidelines and employed a quality scoring system to assess the included papers. Results: Seven papers met the inclusion criteria and were thematically analysed. ALS patients utilized a range of CAM therapies and/or products, with acupuncture and vitamins being the most frequently reported. CAM modalities were often employed concurrently with conventional medications throughout the disease process. Although some ALS patients reported positive experience regarding CAM use, many were reluctant to disclose their CAM use to their clinicians. Research focusing on CAM use in ALS remains ad hoc and restricted to only a few countries. The rigour and quality of this research field to date has been varied, predominantly drawing upon regional/localized data and failing to report CAM users’ characteristics. Conclusion: A proportion of ALS patients report utilizing CAM concurrently with conventional treatments. Such use, set amidst a dearth of evidence for the efficacy of CAM in ALS, poses potential direct and indirect risks to patient care, and medical providers should be mindful of and enquire about CAM use when treating ALS patients. © 2018 S. Karger AG, Basel References Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC: Amyotrophic lateral sclerosis. Lancet 2011; 377: 942–955. Chio A, Mora G, Lauria G: Pain in amyotrophic lateral sclerosis. Lancet Neurol 2017; 16: 144–157. Arthur KC, Calvo A, Price TR, Geiger JT, Chio A, Traynor BJ: Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 2016; 7: 12408. Gladman M, Zinman L: The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res 2015; 15: 439–450. Connolly S, Galvin M, Hardiman O: End-of-life management in patients with amyotrophic lateral sclerosis. Lancet Neurol 2015; 14: 435–442. del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, Van Belle G: Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003; 60: 813–819. Tsai MJ, Hsu CY, Sheu CC: Amyotrophic lateral sclerosis. N Engl J Med 2017; 377: 1602. Wells RE, Phillips RS, Schachter SC, McCarthy EP: Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol 2010; 257: 1822–1831. Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M, Bourdette D, Gronseth GS, Narayanaswami P: Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Acad­emy of Neurology. Neurology 2014; 82: 1083–1092. Fox RJ: Complementary and alternative medicine in multiple sclerosis. Neurology 2014; 82:e103–e107. Alves PD, McClelland J, Morris ME: Complementary physical therapies for movement disorders in Parkinson’s disease: a systematic review. Eur J Phys Rehabil Med 2015; 51: 693–704. Adams J, Andrews G, Barnes J, Broom A, Magin P (eds): Traditional, complementary and integrative medicine: an international reader. London, Palgrave Macmillan, 2012. Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C: Complementary and alternative therapies in amyotrophic lateral sclerosis. Neurol Clin 2015; 33: 909–936. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097. Adams J, Barbery G, Lui CW: Complementary and alternative medicine use for headache and migraine: a critical review of the literature. Headache 2013; 53: 459–473. Peng W, Adams J, Sibbritt DW, Frawley JE: Critical review of complementary and alternative medicine use in menopause: focus on prevalence, motivation, decision-making, and communication. Menopause 2014; 21: 536–548. Adams J, Lui CW, Sibbritt D, Broom A, Wardle J, Homer C, Beck S: Women’s use of complementary and alternative medicine during pregnancy: a critical review of the literature. Birth 2009; 36: 237–245. Wasner M, Klier H, Borasio GD: The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191: 151–154. Pan W, Chen X, Bao J, Bai Y, Lu H, Wang Q, Liu Y, Yuan C, Li W, Liu Z, Liu J: The use of integrative therapies in patients with amyotrophic lateral sclerosis in Shanghai, China. Evid Based Complement Alternat Med 2013; 613596. Hanisch F, Skudlarek A, Berndt J, Kornhuber ME: Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav 2015; 5:e00296. Vardeny O, Bromberg MB: The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS). J Herb Pharmacother 2005; 5: 23–31. Chen L, Zhang B, Chen R, Tang L, Liu R, Yang Y, Yang Y, Liu X, Ye S, Zhan S, Fan D: Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry 2015; 86: 1075–1081. Jefferies KA, Bromberg MB: The role of a clinical pharmacist in a multidisciplinary amyotrophic lateral sclerosis clinic. Amyotroph Lateral Scler 2012; 13: 233–236. Kim S, Chung SE, Lee S, Park J, Choi S, Kim S: Experience of complementary and alternative medicine in patients with amyotrophic lateral sclerosis and their families: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener 2016; 17: 191–197. Olsen SA: A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occup Ther Int 2009; 16: 57–70. Hardiman O: Multidisciplinary care in ALS: expanding the team. Amyotroph Lateral Scler 2012; 13: 165. Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R: Palliative care issues in amyotrophic lateral sclerosis: an evidenced-based review. Am J Hosp Palliat Care 2016; 33: 84–92. Article / Publication Details First-Page PreviewAbstract of Review Received: June 29, 2018 Accepted: August 15, 2018 Published online: September 24, 2018 Issue release date: Published online first Number of Print Pages: 8 Number of Figures: 1 Number of Tables: 4 ISSN: 1660-2854 (Print) eISSN: 1660-2862 (Online) For additional information: https://www.karger.com/NDD Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article Tools Article has an altmetric score of 1 Rightslink Get Permission PubMed PubMed ID Citation Download Add to my Reading List Article Details 2018, Vol.18, No. 4 Published online first previous Article Recommend This Survey 2018 AJE (American Journal Experts) ThinkSCIENCE Psychiatry S. Karger AG